Kemoterapi

Arnold EJ, Childress MO, Fourez LM, Tan KM, Stewart JC, Bonney PL, Knapp DW. Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. Journal of Veterinary Internal Medicine. 2011;25(6):1385–1390.

Barber LG, Sorenmo KU, Cronin KL, Shofer FS. Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma. Journal of the American Animal Hospital Association. 2000;36(5):416–421.

Brodsky EM, Maudlin GN, Lachowicz JL. Asparaginase and MOPP treatment of dogs with lymphoma. Journal of Veterinary Internal Medicine. 2009;23(3):578–584.

Chabner BA, Roberts TG. Timeline: chemotherapy and the war on cancer. Nature Reviews Cancer. 2005;5:65–72.

Custead MR, Weng HY, Childress MO. Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer. Veterinary and Comparative Oncology. 2017;15(4):808–819.

DeVita VT, Chu E. A history of cancer chemotherapy. Cancer Research. 2008;68:8643–8653.

Fernandez R, Chon E. Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs. Journal of Veterinary Internal Medicine. 2018;32(3):1060–1069.

Ghigo A, Li M, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2016;1863(8):1916–1925.

Heading KL, Brockley LK, Bennett PF. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-2007). Australian Veterinary Journal. 2011;89(4):109–116.

Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research. 2003;9(3):906–911.

Hosoya K, Lord LK, Lara‐Garcia A, Kisseberth WC, London CA, Couto CG. Prevalence of elevated alanine transaminase activity in dogs treated with CCNU (lomustine). Veterinary and Comparative Oncology. 2009;7(4):244–255.

Kisseberth WC, Vail DM, Yaissle J, Jeglum KA, Couto CG, Ward H, Khanna C, Obradovich JE. Phase I clinical evaluation of carboplatin in tumor-bearing cats: a veterinary cooperative oncology group study. J Vet Intern Med. 2008;22:83–88.

London CA. Tyrosine kinase inhibitors in veterinary medicine. Top Companion Anim Med. 2009;24:106–112.

Marconato L, Bonfanti U, Stefanello D, Lorenzo MR, Romanelli G, Comazzi S, Zini E. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference? Veterinary and Comparative Oncology. 2008;6(2):80–89.

Martin OA, Price J. Mechlorethamine, vincristine, melphalan and prednisolone rescue chemotherapy protocol for resistant feline lymphoma. Journal of Feline Medicine and Surgery. 2017;19(10):1098612X17735989.

Poirier VJ, Hershey AE, Burgess KE, Phillips B, Turek MM, Forrest LJ, Beaver L, Vail DM. Efficacy and toxicity of paclitaxel (Taxol) for the treatment of canine malignant tumors. Journal of Veterinary Internal Medicine. 2004;18(2):219–222.

Rassnick KM, Al‐Sarraf R, Bailey DB, Chretin JD, Phillips B, Zwhalen CH. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs. Vet Comp Oncol. 2010;8:103–111.

Rassnick KM, Mauldin GE, Al‐Sarraf R, Mauldin GN, Moore AS, Mooney SC. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989–2000). Journal of Veterinary Internal Medicine. 2002;16(5):576–580.

Stein TJ, Pellin M, Steinberg H, Chun R. Treatment of feline gastrointestinal small-cell lymphoma with chlorambucil and glucocorticoids. Journal of the American Animal Hospital Association. 2010;46(6):413–417.

Thamm DH, Vail DM, Post GS, Fan TM, Phillips BS, Axiak‐Bechtel S, Elmslie RS, Klein MK, Ruslander DA. Alternating rabacfosadine/doxorubicin: efficacy and tolerability in naive canine multicentric lymphoma. Journal of Veterinary Internal Medicine. 2017;31(3):872–878.

Turek MM, Forrest LJ, Adams WM, Helfand SC, Vail DM. Postoperative radiotherapy and mitoxantrone for anal sac adenocarcinoma in the dog: 15 cases (1991–2001). Veterinary and Comparative Oncology. 2003;1(2):94–104.

Withrow SJ, Page R, Vail DM. Withrow and MacEwen's small animal clinical oncology. Elsevier Health Sciences; 2012.